Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • General
  • Health Care
  • News
  • Top Stories

Amazon Expands RxPass To Medicare Members: A Closer Look At Savings

By Shivani Kumaresan
June 18, 10:44 AM
Amazon.com Inc. (NASDAQ: AMZN) enhances healthcare accessibility with its RxPass expansion to Medicare beneficiaries, promising an average savings of $70 annually per medication and aiming to reduce Medicare costs by nearly $2 billion.

AMZN

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
June 13, 1:35 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

A

Read More
3 minute read
  • Markets
  • Options

CVS Health’s Options Frenzy: What You Need to Know

By Benzinga Insights
June 11, 2:31 PM
Investors with a lot of money to spend have taken a bullish stance on CVS Health (NYSE:CVS). And…

CVS

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Media
  • News
  • Top Stories

AbbVie’s Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability

By Vandana Singh
June 7, 10:39 AM
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance patient access and incentivize development.

ABBV

Read More
2 minute read
  • Dividends
  • Earnings
  • Long Ideas
  • Markets
  • News
  • Top Stories
  • Trading Ideas

How To Earn $500 A Month From CVS Health Stock

By Avi Kapoor
June 6, 8:42 AM
CVS Health currently has a dividend yield of 4.38%, which is a quarterly dividend amount of 66.5 cents a share ($2.66 a year).

CVS

Read More
3 minute read
  • Markets
  • Options

CVS Health Unusual Options Activity For June 05

By Benzinga Insights
June 5, 11:31 AM
High-rolling investors have positioned themselves bullish on CVS Health (NYSE:CVS), and it’s important for retail traders to take…

CVS

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

Looking Into CVS Health’s Recent Short Interest

By Benzinga Insights
June 4, 12:30 PM
CVS Health’s (NYSE:CVS) short percent of float has fallen 16.51% since its last report. The company recently reported…

CVS

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
May 31, 1:35 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

ABBV

Read More
3 minute read
  • Markets
  • Options

CVS Health’s Options Frenzy: What You Need to Know

By Benzinga Insights
May 31, 1:00 PM
Deep-pocketed investors have adopted a bullish approach towards CVS Health (NYSE:CVS), and it’s something market players shouldn’t ignore.…

CVS

Read More
3 minute read
  • Markets
  • Options

Check Out What Whales Are Doing With CVS

By Benzinga Insights
May 30, 4:16 PM
Financial giants have made a conspicuous bullish move on CVS Health. Our analysis of options history for CVS…

CVS

Posts pagination

1 2 … 39 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service